Search

Your search keyword '"Helga Zoega"' showing total 126 results

Search Constraints

Start Over You searched for: Author "Helga Zoega" Remove constraint Author: "Helga Zoega"
126 results on '"Helga Zoega"'

Search Results

1. History of childhood maltreatment associated with hospitalization or death due to COVID-19: a cohort study

2. Depressive symptom trajectories among general population during the COVID-19 pandemic in Iceland: a prospective cohort study (2020–2023)

3. Psychiatric comorbidities in women with cardiometabolic conditions with and without ADHD: a population-based study

5. Trends in incident diagnoses and drug prescriptions for anxiety and depression during the COVID-19 pandemic: an 18-month follow-up study based on the UK Biobank

6. Consortium for the Study of Pregnancy Treatments (Co-OPT): An international birth cohort to study the effects of antenatal corticosteroids

7. Medication use in populations exposed to the 2010 Eyjafjallajökull eruption: an interrupted time series analysis

8. Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia

9. Medicine treatment of glaucoma in Australia 2012–2019: prevalence, incidence and persistence

10. The international Perinatal Outcomes in the Pandemic (iPOP) study: protocol [version 1; peer review: 2 approved]

11. Maternal and Neonatal Outcomes Associated with Psychostimulant Use in Pregnancy

12. Risks of Squamous Cell Carcinoma of The Lip and Cutaneous Melanoma in Older Australians Using Hydrochlorothiazide (HTCZ)

14. Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016

15. Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia

16. Proton-pump inhibitors among adults: a nationwide drug-utilization study

17. Preeclampsia and academic performance in children: A nationwide study from Iceland.

18. Body Mass Index, Smoking and Hypertensive Disorders during Pregnancy: A Population Based Case-Control Study.

19. Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.

20. Use of benzodiazepines and benzodiazepine‐related drugs in the Nordic countries between 2000 and 2020

21. Trends in labor induction indications: A 20‐year population‐based study

22. Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013–2020)

23. Children's Relative Age and Medicine Treatment for Attention-Deficit/Hyperactivity Disorder Across Australian Jurisdictions with Different School Enrolment Policies

24. Changes in antidepressant use in Australia: A nationwide analysis (2015–2021)

25. Prescribed medicine use and extent of off‐label use according to age in a nationwide sample of Australian children

26. Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries

27. Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US

28. The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis

29. Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

30. Changes in obstetric interventions and preterm birth during COVID‐19: A nationwide study from Iceland

31. Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study

32. Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy

34. Utilisation of teratogenic medicines before and during pregnancy in Australian women

35. Use of proton pump inhibitors and mortality among Icelandic patients with prostate cancer

36. The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictions

37. Application of Federated Analytics in Health Data Research for Reducing Risks Involved in Data Sharing

38. Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations

39. Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future

40. Prescription opioid use in Australian women of reproductive age: Implications for unplanned pregnancies

41. Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics

42. Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

43. The international Perinatal Outcomes in the Pandemic (iPOP) study: Protocol

44. Changes in antibiotic prescribing following COVID_19 restrictions: Lessons for post_pandemic antibiotic stewardship

45. Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia

46. Medication use in populations exposed to the 2010 Eyjafjallajökull eruption: an interrupted time series analysis

47. Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide:A population-based case-control study

48. Enhanced Antenatal Care: Combining one-to-one and group Antenatal Care models to increase childbirth education and address childbirth fear

49. Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia

50. Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016

Catalog

Books, media, physical & digital resources